Published time: 13 April 2020
Authors: Desmond Sutton, M.D., Karin Fuchs, M.D., M.H.A., Mary D’Alton, M.D., Dena Goffman, M.D
Keywords: universal screening, coronavirus, COVID-19
In recent weeks, Covid-19 has rapidly spread throughout New York City. The obstetrical population presents a unique challenge during this pandemic, since these patients have multiple interactions with the health care system and eventually most are admitted to the hospital for delivery. We first diagnosed a case of Covid-19 in an obstetrical patient on March 13, 2020, and we previously reported our early experience with Covid-19 in pregnant women, including two initially asymptomatic women in whom symptoms developed and who tested positive for SARS-CoV-2, the virus that causes Covid-19, after delivery.1,2 After these two cases were identified, we implemented universal testing with nasopharyngeal swabs and a quantitative polymerase-chain-reaction test to detect SARS-CoV-2 infection in women who were admitted for delivery.
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery